CARACO PHARMACEUTICAL LABORATORIES LTD - FORM 10-Q - EX-32.1 - EXHIBIT 32.1 - February 9, 2011

Attached files

file filename
EX-10.35 - EXHIBIT 10.35 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_35.htm
EX-31.1 - EXHIBIT 31.1 - CARACO PHARMACEUTICAL LABORATORIES LTDex31_1.htm
EX-31.2 - EXHIBIT 31.2 - CARACO PHARMACEUTICAL LABORATORIES LTDex31_2.htm
EX-10.34 - EXHIBIT 10.34 - CARACO PHARMACEUTICAL LABORATORIES LTDex10_34.htm
10-Q - CARACO PHARMACEUTICAL LABORATORIES, LTD 10-Q 12-31-2010 - CARACO PHARMACEUTICAL LABORATORIES LTDform10q.htm
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the accompanying Quarterly Report on Form 10-Q of Caraco Pharmaceutical Laboratories, Ltd. (“Caraco”) for the period ended December 31, 2010 (the “Report”), the undersigned hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of their respective knowledge and belief, that:

(1)  The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Caraco.

 
/s/ GP. Singh Sachdeva
 
GP. Singh Sachdeva
 
Chief Executive Officer
   
 
/s/ Mukul Rathi
 
Mukul Rathi
 
Interim Chief Financial Officer

Date:  February 9, 2011
 
 

CARACO PHARMACEUTICAL LABORATORIES LTD Reports